Likewise, S100A1 is up-regulated in a disease-specific manner, so developing S100A1-specific inhibitors may aid in treating diabetes, neurological diseases, heart failure, and other cancers [5,10,11,12,13,14]. The gene discussed is S100A1; the disease is diabetes mellitus.